Dr Art Walaszek joins Ethics Talk to discuss his article, coauthored with Drs William Smith and David Elkin: “How to Draw on Narrative to Mitigate Ageism.”
I’m sorry laws, enacted in the majority of states, encourage physicians to apologize for unexpected outcomes and errors by making such apologies inadmissible in civil court to prove liability.
Maureen Kelley, PhD discusses the dual-use dilemma in infectious disease research. The same scientific information or products intended for good can also fall into the wrong hands and be used to threaten a population in an act of bioterrorism.
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.
Web-based physician rating sites are part of a multi-decade cultural shift in the relationship between physicians, patients, and society. But a system in which “patient’s orders” reign is just as lopsided as one that puts “doctor’s orders” in the driver’s seat.
The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions.
Anne Drapkin Lyerly, MD, MA and Ruth R. Faden, PhD, MPH
Participation in a research study—in which there are rigorous standards and close monitoring—may be a safer context for the use of medications in pregnancy than the clinical setting, where the evidence base is lacking.
Addicts quickly learn the diagnoses that cannot be definitively confirmed or ruled out by examinations or test results but that elicit prescriptions for opioid pain management.